Cormorant
Investor profile
Venture capital
Cormorant has backed 1 European tech company across 1 funding round in 2025, joining rounds totalling €90M. Most active in Healthtech. Data as of 4 Nov 2026.
Deals
1
distinct rounds
Companies
1
backed
Active span
2025
1 yr
Total round €
€90M
sum of rounds joined
Deals by year
distinct rounds / yearCormorant — deals by year — interactive chart.
Data table
| Cormorant — deals by year | |
|---|---|
| 2025 | 1 |
Top sectors
by dealsCormorant — top sectors — interactive chart.
Data table
| Cormorant — top sectors | |
|---|---|
| Healthtech | 1 |
Stages
by dealsCormorant — stages — interactive chart.
Data table
| Cormorant — stages | |
|---|---|
| Series A | 1 |
Countries
by dealsCormorant — countries — interactive chart.
Data table
| Cormorant — countries | |
|---|---|
| Denmark | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Orbis Medicines | Denmark | 1 | €90M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Orbis Medicines | Series A | €90M | 2025-01 |